MedPath

Effects of testosterone on urea metabolism in men with hypogonadism

Phase 4
Completed
Conditions
Hypogonadism
Metabolic and Endocrine - Other endocrine disorders
Metabolic and Endocrine - Other metabolic disorders
Registration Number
ACTRN12616000577415
Lead Sponsor
Western Sydney Local Health District
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
8
Inclusion Criteria

1.Diagnosed hypogonadism;
2.Adequate replacement of other hormones in case of hypopituitarism;
3.Able to comprehend the requirements and procedures for the study and to provide informed consent before entering the study

Exclusion Criteria

1.Any acute condition or exacerbation of chronic conditions that in the investigators opinion would interfere with the trial visit schedule and procedures;
2.Cancer, diabetes mellitus, immunosuppressive steroid therapy and chronic renal or hepatic illnesses;
3.People in existing dependent or unequal relationships with any member of the research team;
4.People who may be involved in illegal activity;
5.People highly dependent on medical care;
6.Patients who had received an investigational new drug within the last 6 month;
7.Patients with a cognitive impairment, an intellectual disability or a mental condition which interfere with the patient's ability to understand the requirements of the study;
8.Inability to give written informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rea metabolism, assessed by plasma urea turnover studies using stable isotopes[At baseline and 2 weeks post commencement of testosterone treatment.]
Secondary Outcome Measures
NameTimeMethod
Protein metabolism by plasma leucine turnover studies using stable isotopes[At baseline and 2 weeks post commencement of testosterone treatment.]
© Copyright 2025. All Rights Reserved by MedPath